Aura Biosciences announced inducement equity awards for its new CEO and President, Natalie Holles, including stock options, restricted stock units (RSUs), and performance-based RSUs (PRSUs). These awards, approved under Nasdaq Listing Rule 5635(c)(4), are designed to incentivize Ms. Holles with vesting schedules tied to her continued service and performance milestones. This move aligns with Aura's strategy to strengthen leadership as it advances its clinical-stage therapies for solid tumors. The inducement grants support the company's growth and innovation goals in oncology treatment development.
First Capital, Inc. announced a quarterly cash dividend of $0.31 per share, to be paid on June 26, 2026. The dividend applies to shareholders of record as of June 12, 2026. This dividend reflects the company's ongoing commitment to returning value to...
Farmers and Merchants Bancshares, Inc. announced a 5.9% increase in its cash dividend to $0.36 per share, payable on June 18, 2026, to shareholders of record as of June 2, 2026. This dividend hike reflects the company's strong financial position and ...
8x8 reported Q4 adjusted earnings of 11 cents per share, beating the 8-cent estimate, and revenue of $185.25 million, surpassing the $181.12 million forecast. The company achieved record service revenue for the quarter and full year, with over 50% gr...
Quest Diagnostics announced that its Board of Directors has declared a quarterly cash dividend of $0.86 per share. The dividend will be paid on July 22, 2026, to shareholders of record as of July 8, 2026. This dividend reflects the company's ongoing ...
In Q1 2026, Bill Ackman sold 95% of his Alphabet shares, missing out on $641 million in gains as the stock surged. He shifted his investment to Microsoft, which gained $271.8 million since the end of the quarter, partially offsetting the losses. Ackm...
